Peter,
I am not patent attorney, nor can judge or comment (with confidence that I am close to be right) in regards the 502 patent and IP right on PBN-disulfate derivative.
Second, as man to man, I wish that you prevail on ALL YOUR EFORTS, and be adequately compensated.
My view is that "doctrine of equivalence" can be shifted one way or another, and that in claim 2. you should have covered other methods, not only topical.
Again, I am not up to speed on any bio-related topic, as I was in 96-01 period.
One question, if I may:
1. Are you looking to be compensated on Cerovine with satisfied royalty (+milestones), or you want to take ALL RNVS revenue from AZN?
Thanks,
Miljenko |
